Advaxis Receives Additional Financing

Advaxis, Inc . , (OTCBB: ADXS) , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million. The closing of the sale of the Notes, under the Agreement, is anticipated to ...continued ADXS RODM  companies finance investment

URL: http://www.investorpoint.com/news/OTCBULLB/47200216/